A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/1999
12/15/1999	CN1238200A Medical capsule for regulating insulin and reducing blood and/or uric sugar
12/15/1999	CN1238181A Nefazodone dosage form
12/15/1999	CN1238180A Medicinal composition for curing sexual function involution and impotence and preparing process thereof
12/15/1999	CN1238179A 避孕栓 Contraceptive suppository
12/15/1999	CN1238178A Process for preparing ointment suppository contained in plastic bag
12/15/1999	CN1047329C Multi-dentate heterodesmic Rh catalyst and its preparation method and use
12/15/1999	CN1047315C Chinese medicine powder capsule for eliminating numbness and preparing method
12/15/1999	CN1047314C Liquid hypotensor with cephalocatharic function
12/15/1999	CN1047311C Traditional Chinese medicine for treatment of paraplegia
12/15/1999	CN1047305C 可注射的组合物 Injectable compositions
12/14/1999	US6002961 Transdermal protein delivery using low-frequency sonophoresis
12/14/1999	US6002029 Antiviral prodrugs
12/14/1999	US6001895 Composite surgical material
12/14/1999	US6001870 Nasopharynx administration of mupirocin for prophylactic treatment of recurrent otitis media
12/14/1999	US6001853 Composition further comprising a reducing agent for maintaining the hydroxylamine in a reduced form.
12/14/1999	US6001822 Antiparasitic formulations
12/14/1999	US6001819 Bacterial inhibition with an oligosaccharide compound
12/14/1999	US6001817 In nucleotide carrier; anticancer agents; aids therapy
12/14/1999	US6001800 Atomizing into hot air an aqueous solution of recombitant human erythropoietin to evapororate sprayed particles to dryness, separating
12/14/1999	US6001644 Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
12/14/1999	US6001554 Powder composed of particles consisting of an oleophilic substance encapsulated in a water soluble cellulose polymer; for high potency, dry and free-flowing vitamin powders
12/14/1999	US6001395 Polymeric lamellar substrate particles for drug delivery
12/14/1999	US6001392 Antitussive drugs delivered by ion exchange resins
12/14/1999	US6001391 Molding a melt of a polymeric binder with or without at least one active ingredient, there being at least one solid product, which may contain an active ingredient incorporated into the still plastic composition during the molding step
12/14/1999	US6001390 Formulations for transdermal delivery of pergolide
12/14/1999	US6001387 Spin disk encapsulation apparatus and method of use
12/14/1999	US6001386 For treatment of uveitis eye disease
12/14/1999	US6001385 Solid products produced by extruding and/or injection moulding raw materials based on destructurized starch and/or containing starch, which products are intended for transdermal applications
12/14/1999	US6001348 An nad (nicotinamide-adenine dinucleotide)-independent live attenuated strain of mycoplasma synoviae; and less expensive vaccines for protecting poultry against mycoplasma synoviae
12/14/1999	US6001347 Organic acid compound of given structure having an aromatic amide group, a methoxy group in the ortho position on the aromatic ring, and a lipophilic chain terminated with a carboxylic acid is useful as a nontoxic carrier
12/14/1999	US6001336 Processes for spray drying aqueous suspensions of hydrophobic drugs and compositions thereof
12/14/1999	US6001335 Synthesizing a lipid vesicle having a gas encapsulated therein for ultrasonic imaging, by subjecting a solvent-free composition of a gaseous precursor and lipid in aqueous medium to a first pressure, then a second lower pressure
12/14/1999	US6001334 Barium powder of large, medium and small particle sizes in specific weight ratios, coated with a composite additive of gum tragacanth and carageenan in specific ratios depending on particle size and surface area; no parasympatholytic agents
12/14/1999	US6001090 Thermal pharmaceutical delivery system
12/14/1999	CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999	CA2180334C Coprocessed galactomannan - glucomannan
12/14/1999	CA2160071C Cosmetic or dermatologic composition containing a cristallized liquid lamellar coated oily globules oil-in-water emulsion
12/14/1999	CA2138873C Composition against acne insuring the simultaneous treatment of the superficial and deep layers of the skin, and its use
12/14/1999	CA2095642C Adhesion receptors for pathogenic or opportunistic microorganisms
12/14/1999	CA2074503C Pharmaceutical formulation containing penciclovir
12/14/1999	CA2046830C Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
12/14/1999	CA2001536C Self-foaming oil compositions and process for making and using same
12/10/1999	CA2274294A1 Blackhead removing agent, blackhead removing sheet, and method for producing blackhead removing sheet
12/09/1999	WO1999062983A1 Polyethylene glycol-polyorthoester, polyethylene glycol-polyorthoester-polythylene glycol, and polyorthoester-polyethylene glycol-polyorthoester block copolymers
12/09/1999	WO1999062856A2 Citric acid doped with alkaline or alkaline-earth ions
12/09/1999	WO1999062560A1 Stabilization of compositions containing ace inhibitors using magnesium oxide
12/09/1999	WO1999062559A1 Pharmaceutical tablets comprising cefuroxime axetil
12/09/1999	WO1999062558A1 Insulin supplemented infant formula
12/09/1999	WO1999062557A1 Composition for the transdermal administration of non-steroidal anti-inflammatory drugs
12/09/1999	WO1999062552A1 Adhesion / fixation / cooling remedies for burn and therapeutic method for relieving burn scar
12/09/1999	WO1999062546A1 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
12/09/1999	WO1999062542A1 Recombinant human interferon beta-1a (ifn-beta-1a) formulation
12/09/1999	WO1999062533A1 Preparation for topical application to the male sexual organ
12/09/1999	WO1999062516A1 A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer
12/09/1999	WO1999062510A2 Compositions comprising anti-microtubule agents for treating or preventing inflammatory diseases
12/09/1999	WO1999062504A2 Topical administration of oxazolidinones for transdermal delivery
12/09/1999	WO1999062501A1 Controlled release preparations having multi-layer structure
12/09/1999	WO1999062500A1 Stabilizers for lyophilized vaccines
12/09/1999	WO1999062499A1 Stabilized pharmaceutical compositions
12/09/1999	WO1999062498A1 Spill resistant pharmaceutical compositions
12/09/1999	WO1999062497A1 Stable gel mixture in the form of a mixture of oleogel and aqueous gel
12/09/1999	WO1999062496A1 Methods and devices for providing prolonged drug therapy
12/09/1999	WO1999062471A1 Dentifrice composition containing encapsulated reactive ingredients
12/09/1999	WO1999062470A1 Devices with coatings containing chlorhexidine gluconate, compositions and methods
12/09/1999	WO1999062463A1 α-HYDROXY FATTY ACID DERIVATIVES AND COMPOSITION FOR EXTERNAL USE CONTAINING THE SAME
12/09/1999	WO1999062444A1 Silk clothes for protecting affected parts
12/09/1999	WO1999062403A1 Apparatus and method for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
12/09/1999	WO1999056729B1 Cholesterol lowering composition
12/09/1999	WO1999048506A3 Composition containing at least one metal yeast for pharmaceutical use and/or for use as a nutrition supplement, for humans or animals
12/09/1999	WO1999047678A3 Interferon alpha plasmids and delivery systems, and methods of making and using the same
12/09/1999	WO1999038528A3 Vaccine formulations
12/09/1999	WO1999032152A3 Methods for delivering pharmaceutical agents to mucosal surfaces
12/09/1999	DE19910251A1 Encapsulation of microbial, plant and animal cells or biological or chemical substances in spherical particles, may be used e.g. in immobilization of catalysts and enzymes
12/09/1999	DE19825499A1 Wirkstoffhaltige Pflaster Active substance plasters
12/09/1999	DE19825447A1 Neue Insulinanaloga mit erhöhter Zinkbildung New insulin analogues with increased zinc Education
12/09/1999	CA2334144A1 Dentifrice composition containing encapsulated reactive ingredients
12/09/1999	CA2333688A1 Methods and devices for providing prolonged drug therapy
12/09/1999	CA2333505A1 Stabilizers for lyophilized vaccines
12/09/1999	CA2333063A1 Recombinant human interferon beta-1a (ifn-beta-1a) formulation
12/09/1999	CA2333009A1 Devices with coatings containing chlorhexidine gluconate, compositions and methods
12/09/1999	CA2332333A1 Peg-poe, peg-poe-peg, and poe-peg-poe block copolymers
12/09/1999	CA2330581A1 Stabilization of compositions containing ace inhibitors using magnesium oxide
12/09/1999	CA2327326A1 Topical administration of oxazolidinones for transdermal delivery
12/08/1999	EP0962453A1 Histidine derivatives, process for their preparation and their uses
12/08/1999	EP0962443A1 Citric acid enriched in alkali or alkaline-earth ions
12/08/1999	EP0962226A1 External preparations containing watercress extract
12/08/1999	EP0962225A2 Use of phentolamine for the manufacture of a medicament for the treatment of erectile dysfunction
12/08/1999	EP0961801A1 Monomers derived from hydroxy acids and polymers prepared therefrom
12/08/1999	EP0961794A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
12/08/1999	EP0961651A1 Method & apparatus for the formation of particles
12/08/1999	EP0961616A1 Non-hormonal method of contraception
12/08/1999	EP0961612A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
12/08/1999	EP0961611A2 Expandable gastro-retentive therapeutic system with controlled active substance release in the gastro-intestinal tract
12/08/1999	EP0961610A1 Skin preparation
12/08/1999	EP0961602A1 Contour of a transdermal therapeutic system
12/08/1999	EP0809803A4 Three-dimensional colorimetric assay assemblies
12/08/1999	EP0765155B1 Non-irritant aqueous liposome dispersions containing alpha-hydroxycarboxylic acids, alpha-ketocarboxylic acids and/or salicyclic acid in their salt forms
12/08/1999	EP0702565B1 Helicobacter pylori catalase-based immunising composition
12/08/1999	CN1237908A Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
12/08/1999	CN1237907A Formulation for electrically assisted delivery of lidocaine and epinephrine

1 ... 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 ... 2991